Ramona Britto
Overview
Explore the profile of Ramona Britto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
210
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen Q, Britto R, Erill I, Jeffery C, Liberzon A, Magrane M, et al.
Genomics Proteomics Bioinformatics
. 2020 Jul;
18(2):91-103.
PMID: 32652120
No abstract available.
2.
Bursteinas B, Britto R, Bely B, Auchincloss A, Rivoire C, Redaschi N, et al.
Database (Oxford)
. 2016 Dec;
2016.
PMID: 28025334
Advances in high-throughput sequencing have led to an unprecedented growth in genome sequences being submitted to biological databases. In particular, the sequencing of large numbers of nearly identical bacterial genomes...
3.
Britto R, Sallou O, Collin O, Michaux G, Primig M, Chalmel F
Nucleic Acids Res
. 2012 May;
40(Web Server issue):W458-65.
PMID: 22570409
We present gene prioritization system (GPSy), a cross-species gene prioritization system that facilitates the arduous but critical task of prioritizing genes for follow-up functional analyses. GPSy's modular design with regard...
4.
Das S, Sinha S, Britto R, Somasundaram K, Samuelson A
J Inorg Biochem
. 2009 Nov;
104(2):93-104.
PMID: 19913918
Neutral and cationic organometallic ruthenium(II) piano stool complexes of the type [(eta(6)-cymene)RuCl(X)(Y)] (complexes R1-R8) has been synthesized and characterized. In cationic complexes, X, Y is either a eta(2) phosphorus ligand...
5.
Reddy S, Britto R, Vinnakota K, Aparna H, Sreepathi H, Thota B, et al.
Clin Cancer Res
. 2008 May;
14(10):2978-87.
PMID: 18483363
Purpose: Current methods of classification of astrocytoma based on histopathologic methods are often subjective and less accurate. Although patients with glioblastoma have grave prognosis, significant variability in patient outcome is...
6.
Britto R, Umesh S, Hegde A, Hegde S, Santosh V, Chandramouli B, et al.
Cancer Biol Ther
. 2007 May;
6(3):413-8.
PMID: 17471019
Activator protein 2alpha (AP-2alpha) has been shown to be lost in the advanced stages of many cancers, including gliomas. In this study, we wanted to analyze the expression of AP-2alpha...
7.
Wajapeyee N, Britto R, Ravishankar H, Somasundaram K
J Biol Chem
. 2006 Mar;
281(24):16207-19.
PMID: 16533807
Activator protein 2alpha (AP-2alpha) induces cytotoxicity by inducing cell cycle arrest and apoptosis. In this study we investigated the mechanism of apoptosis induction by AP-2alpha. We found that AP-2alpha induced...
8.
Upregulation of ASCL1 and inhibition of Notch signaling pathway characterize progressive astrocytoma
Somasundaram K, Reddy S, Vinnakota K, Britto R, Subbarayan M, Nambiar S, et al.
Oncogene
. 2005 Aug;
24(47):7073-83.
PMID: 16103883
Astrocytoma is the most common type of brain cancer constituting more than half of all brain tumors. With an aim to identify markers describing astrocytoma progression, we have carried out...
9.
Britto R, Somasundaram K
Cancer Biol Ther
. 2005 Jan;
3(11):1135-6.
PMID: 15640615
No abstract available.